Long-term survival in older patients given propofol or sevoflurane anaesthesia for major cancer surgery: follow-up of a multicentre randomised trial

被引：18

作者：

Cao, Shuang-Jie ^{[1
]}

Zhang, Yue ^{[1
,2
]}

Zhang, Yu-Xiu ^{[1
]}

Zhao, Wei ^{[3
]}

Pan, Ling -Hui ^{[4
]}

Sun, Xu-De ^{[5
]}

Jia, Zhen ^{[6
]}

Ouyang, Wen ^{[7
]}

Ye, Qing-Shan ^{[8
]}

Zhang, Fang -Xiang ^{[9
]}

Guo, Yong-Qing ^{[10
]}

Ai, Yan-Qiu ^{[11
]}

Zhao, Bin -Jiang ^{[12
]}

Yu, Jian-Bo ^{[13
]}

Liu, Zhi-Heng ^{[14
]}

Yin, Ning ^{[15
,16
]}

Li, Xue-Ying ^{[17
]}

Ma, Jia-Hui ^{[1
]}

Li, Hui -Juan ^{[18
]}

Wang, Mei-Rong ^{[18
]}

Sessler, Daniel I. ^{[19
,21
]}

Ma, Daqing ^{[20
,22
]}

Wang, Dong-Xin ^{[1
,19
]}

机构：

[1] Peking Univ First Hosp, Dept Anesthesiol, Beijing, Peoples R China

[2] Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Clin Res Inst, Shenzhen, Peoples R China

[3] Hebei Med Univ, Dept Anesthesiol, Hosp 4, Shijiazhuang, Hebei, Peoples R China

[4] Guangxi Med Univ, Dept Anesthesiol, Dept Radiat Oncol, Canc Hosp, Nanning, Guangxi Zhuang, Peoples R China

[5] Fourth Mil Med Univ, Air Force Med Univ, Tangdu Hosp, Dept Anesthesiol, Xian, Shaanxi, Peoples R China

[6] Qinghai Univ, Dept Anesthesiol, Affiliated Hosp, Xining, Qinghai, Peoples R China

[7] Cent South Univ, Xiangya Hosp 3, Dept Anesthesiol, Changsha, Hunan, Peoples R China

[8] Peoples Hosp Ningxia Hui Autonomous Reg, Dept Anesthesiol, Yinchuan, Ningxia Hui Aut, Peoples R China

[9] Guizhou Prov Peoples Hosp, Dept Anesthesiol, Guiyang, Guizhou, Peoples R China

[10] Shanxi Prov Peoples Hosp, Dept Anesthesiol, Taiyuan, Shanxi, Peoples R China

[11] Zhengzhou Univ, Dept Anesthesiol Pain & Perioperat Med, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China

[12] Capital Med Univ, Beijing Shijitan Hosp, Dept Anesthesiol, Beijing, Peoples R China

[13] Tianjin Med Univ, Tianjin Nankai Hosp, Dept Anesthesiol & Crit Care Med, Tianjin, Peoples R China

[14] Shenzhen Univ, Shenzhen Peoples Hosp 2, Hlth Sci Ctr, Dept Anesthesiol,Affiliated Hosp 1, Shenzhen, Guangdong, Peoples R China

[15] Southeast Univ, Zhongda Hosp, Med Sch, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China

[16] Nanjing Med Univ, Sir Run Run Hosp, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China

[17] Peking Univ First Hosp, Dept Biostat, Beijing, Peoples R China

[18] Peking Univ, Clin Res Inst, Hlth Sci Ctr, Beijing, Peoples R China

[19] Cleveland Clin, Outcomes Res Consortium, Cleveland, OH 44106 USA

[20] Imperial Coll London, Chelsea & Westminster Hosp, Fac Med, Div Anaesthet Pain Med & Intens Care,Dept Surg &, London, England

[21] Anesthesiol Inst, Dept Outcomes Res, Cleveland, OH USA

[22] Natl Clin Res Ctr Child Hlth, Hangzhou, Peoples R China

来源：

BRITISH JOURNAL OF ANAESTHESIA | 2023年 / 131卷 / 02期

关键词：

aged; cancer surgery; inhalation anaesthesia; intravenous anaesthesia; morbidity; propofol; sevoflurane; survival; TOTAL INTRAVENOUS ANESTHESIA; GENERAL-ANESTHESIA; METASTASIS; VOLATILE; LIFE; ISOFLURANE; QUALITY; PATHWAY;

D O I：

10.1016/j.bja.2023.01.023

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

Background: Experimental evidence indicates that i.v. anaesthesia might reduce cancer recurrence compared with volatile anaesthesia, but clinical information is observational only. We therefore tested the primary hypothesis that propofol-based anaesthesia improves survival over 3 or more years after potentially curative major cancer surgery. Methods: This was a long-term follow-up of a multicentre randomised trial in 14 tertiary hospitals in China. We enrolled 1228 patients aged 65 - 90 yr who were scheduled for major cancer surgery. They were randomised to either propofolbased i.v. anaesthesia or to sevoflurane-based inhalational anaesthesia. The primary endpoint was overall survival after surgery. Secondary endpoints included recurrence -free and event -free survival. Results: Amongst subjects randomised, 1195 (mean age 72 yr; 773 [65%] male) were included in the modified intention -totreat analysis. At the end of follow-up (median 43 months), there were 188 deaths amongst 598 patients (31%) assigned to propofol-based anaesthesia compared with 175 deaths amongst 597 patients (29%) assigned to sevoflurane-based anaesthesia; adjusted hazard ratio 1.02; 95% confidence interval (CI): 0.83 - 1.26; P = 0.834. Recurrence -free survival was 223/598 (37%) in patients given propofol anaesthesia vs 206/597 (35%) given sevoflurane anaesthesia; adjusted hazard ratio 1.07; 95% CI: 0.89 - 1.30; P = 0.465. Event -free survival was 294/598 (49%) in patients given propofol anaesthesia vs 274/ 597 (46%) given sevoflurane anaesthesia; adjusted hazard ratio 1.09; 95% CI 0.93 to 1.29; P = 0.298. Conclusions: Long-term survival after major cancer surgery was similar with i.v. and volatile anaesthesia. Propofol-based iv. anaesthesia should not be used for cancer surgery with the expectation that it will improve overall or cancer -specific survival. Clinical trial registrations: ChiCTR-IPR-15006209; NCT02660411.

引用

页码：266 / 275

页数：10

共 44 条

[1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY
AARONSON, NK
AHMEDZAI, S
BERGMAN, B
BULLINGER, M
CULL, A
DUEZ, NJ
FILIBERTI, A
FLECHTNER, H
FLEISHMAN, SB
DEHAES, JCJM
KAASA, S
KLEE, M
OSOBA, D
RAZAVI, D
ROFE, PB
SCHRAUB, S
SNEEUW, K
SULLIVAN, M
TAKEDA, F
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 365 - 376
[2] Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
Austin, Peter C.
[J]. STATISTICS IN MEDICINE, 2009, 28 (25) : 3083 - 3107
[3] Isoflurane, a Commonly Used Volatile Anesthetic, Enhances Renal Cancer Growth and Malignant Potential via the Hypoxia-inducible Factor Cellular Signaling Pathway In Vitro
Benzonana, Laura L.
Perry, Nicholas J. S.
Watts, Helena R.
Yang, Bob
Perry, Iain A.
Coombes, Charles
Takata, Masao
Ma, Daqing
[J]. ANESTHESIOLOGY, 2013, 119 (03) : 593 - 605
[4] Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: a pilot study
Buckley, A.
McQuaid, S.
Johnson, P.
Buggy, D. J.
[J]. BRITISH JOURNAL OF ANAESTHESIA, 2014, 113 : 56 - 62
[5] Cao SJ, Br J Anaesth under review
[6] Quality, interpretation and presentation of European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30 data in randomised controlled trials
Cocks, Kim
King, Madeleine T.
Velikova, Galina
Fayers, Peter M.
Brown, Julia M.
[J]. EUROPEAN JOURNAL OF CANCER, 2008, 44 (13) : 1793 - 1798
[7] Impact of Anesthesia on Long-term Outcomes in Patients With Supratentorial High-grade Glioma Undergoing Tumor Resection: A Retrospective Cohort Study
Dong, Jia
Zeng, Min
Ji, Nan
Hao, Shuyu
Zhou, Yang
Gao, Zhixian
Gu, Hongqiu
Zhang, Li
Ma, Daqing
Peng, Yuming
Han, Ruquan
[J]. JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 2020, 32 (03) : 227 - 233
[8] Long-term Survival after Combined Epidural-General Anesthesia or General Anesthesia Alone: Follow-up of a Randomized Trial
Du, Ya-Ting
Li, Ya-Wei
Zhao, Bin-Jiang
Guo, Xiang-Yang
Feng, Yi
Zuo, Ming-Zhang
Fu, Cong
Zhou, Wei-Jie
Li, Huai-Jin
Liu, Ya-Fei
Cheng, Tong
Mu, Dong-Liang
Zeng, Yuan
Liu, Peng-Fei
Li, Yan
An, Hai-Yan
Zhu, Sai-Nan
Li, Xue-Ying
Li, Hui-Juan
Wu, Yang-Feng
Wang, Dong-Xin
Sessler, Daniel I.
[J]. ANESTHESIOLOGY, 2021, 135 (02) : 233 - 245
[9] Volatile anaesthesia and peri-operative outcomes related to cancer: a feasibility and pilot study for a large randomised control trial
Dubowitz, J. A.
Cata, J. P.
De Silva, A. P.
Braat, S.
Shan, D.
Yee, K.
Hollande, F.
Martin, O.
Sloan, E. K.
Riedel, B.
[J]. ANAESTHESIA, 2021, 76 (09) : 1198 - 1206
[10] Edge SB., 2010, AM JOINT COMMITTEE C, V7th

← 1 2 3 4 5 →